AI can help pharmacovigilance teams identify ICSR-relevant literature faster by screening large volumes of scientific publications, prioritizing high-risk articles, and keeping expert reviewers in control. This supports faster safety review, better focus, and more consistent ICSR detection workflows.

ICSR bulk AI review helps pharmacovigilance teams screen large volumes of literature records faster while keeping human reviewers in control. By importing cases, applying AI-assisted screening, validating results, and finalizing decisions, teams can reduce manual effort and improve review consistency.